SEC Form 4 · accession 0001450324-15-000006
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas K. Equels
Officer — CFO, Pres.,Sec., Vice Chairman · Director
Period of report
Aug 13, 2015
Accepted (ET)
Aug 14, 2015 · 10:59 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 13, 2015 | P | 16,504 | $0.1798 | A | 1,321,948 | D | |
| Common Stock | Aug 13, 2015 | P | 12,600 | $0.18 | A | 1,334,548 | D | |
| Common Stock | Aug 14, 2015 | P | 50,000 | $0.1801 | A | 1,384,548 | D |
Table II — derivative securities
No Table II lines on this filing.